Table 2 Patients’ demographics and CTO target vessel.

From: The comparison of efficacy and safety between transradial and transfemoral approach for chronic total occlusions intervention: a meta-analysis

 

TRA

TFA

p value

Age (years)

3.8 ± 10.8 (4365)

64.5 ± 10.5 (7371)

< 0.001

Male sex (%)

82.0 (3578)

81.5 (6005)

1.000

Diabetes mellitus (%)

27.7(1209)

33.0 (2430)

< 0.001

Hypertension (%)

69.2 (3019)

72.6 (5350)

< 0.001

Dyslipidemia (%)

70.8 (1145)

83.6(3042)

< 0.001

Heart failure (%)

19.5 (825)

22.1 (1619)

< 0.001

Prior MI (%)

38.8 (1695)

41.5 (3056)

0.004

Prior CABG (%)

11.6 (506)

22.4 (1652)

< 0.001

CTO target vessel

LAD

35.0 (1538)

29.2 (2164)

< 0.001

LCX

24.5 (1078)

18.3 (1356)

< 0.001

RCA

47.4 (2085)

54.8 (4063)

< 0.001

J-CTO score

2.0 ± 1.2 (1636)

2.4 ± 1.3 (3681)

< 0.001

Sheath size (Fr)

6.6 ± 0.5 (1280)

7.3 ± 0.7 (2683)

< 0.001

Procedure time (min)

87.8 ± 36.9 (1053)

106.8 ± 47.5 (3146)

< 0.001

Fluoroscopy time (min)

34.2 ± 22.1 (1647)

40.5 ± 21.9 (3682)

< 0.001

Contrast volume (ml)

244.2 ± 128.2 (1647)

272.4 ± 101.2 (3657)

< 0.001

  1. Data are expressed as mean ± standard deviation or as number (percentage).
  2. CTO chronic total occlusion, TRA transradial access, TFA transfemoral access, MI myocardial infarction, CABG coronary artery bypass graft, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, J-CTO Japan chronic total occlusion, Fr French.
Back to article page